Methylphenidate-Induced Enuresis: 3 Case Reports
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children and adolescents. Methylphenidate (MPH) is one of the most widely used drugs in the treatment of ADHD. Enuresis can occur comorbidly with ADHD. However, enuresis is sometimes seen in patients with ADHD...
Saved in:
Published in | Clinical neuropharmacology Vol. 44; no. 1; p. 37 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
01.01.2021
|
Online Access | Get more information |
Cover
Loading…
Summary: | Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children and adolescents. Methylphenidate (MPH) is one of the most widely used drugs in the treatment of ADHD. Enuresis can occur comorbidly with ADHD. However, enuresis is sometimes seen in patients with ADHD as an adverse effect of MPH treatment. In contrast, in some cases, MPH reportedly improves enuresis in patients with ADHD comorbid with enuresis. The literature is contradictory with regard to the relationship between MPH and enuresis. This report presents the cases of 3 children with ADHD who displayed enuresis during MPH treatment. |
---|---|
ISSN: | 1537-162X |
DOI: | 10.1097/WNF.0000000000000422 |